Skip to main content
# العنوان سنة البحث
141 Serum profiles of extracellular matrix degradation inhibitors arcross the stages of liver fibrosis in chronic hepatitis C patients 2014
142 Comparison of circulating Endothelial Cell/Platelet Count ratio to Aspartate Transaminase/platelet ratio index for identifying patients with cirrhosis 2014
143 Impact of Liver Biopsy on the Decision to Treat Patients with Chronic Hepatitis B Genotype D Virus Infection. 2014
144 Fungal infection in patients with end-stage liver disease: low frequency or low index of suspicion 2014
145 FECAL OCCULT BLOOD AS SCREENING TEST FOR UPPER GASTROINTESTINAL MUCOSAL CHANGES IN PATIENTS WITH END STAGE RENAL DISEASE 2013
146 A revised scope in different prognostic models in cirrhotic patients: Current and future perspectives, an Egyptian experience 2013
147 FECAL OCCULT BLOOD AS SCREENING TEST FOR UPPER GASTROINTESTINAL MUCOSAL CHANGES IN PATIENTS WITH END STAGE RENAL DISEASE 2013
148 Pre-treatment role of inosine triphosphate pyrophosphatase polymorphism for predicting anemia in Egyptian hepatitis C virus patients. 2013
149 Virologic and histologic characterisation of dual hepatitis B and C co-infection in Egyptian patients 2013
150 N-Terminal Pro-Brain Natriuretic Peptide: Prognostic Potential in End
Stage Liver Cirrhosis in a Cohort Free of Heart Failure; an Egyptian
Insight
2013